Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA

Abstract

Somatic mutation of the FLT3 gene as an internal tandem duplication (ITD) of the juxtamembrane domain-coding sequence causes constitutive tyrosine phosphorylation and activation. Tumor-specific DNA has been documented in the sera of patients with solid tumors even when it is in an early stage. We compared the detection of FLT3 ITD in DNA extracted from cells of bone marrow (BM) aspirations with DNA extracted from peripheral blood (PB) plasma in patients newly diagnosed with acute myeloid leukemia (AML; 85 patients), myelodysplastic syndrome (MDS; 16 patients), and acute lymphocytic leukemia (ALL; 16 patients). FLT3 ITD was detected in 18 (21%) AML samples and in one (6%) MDS sample in both cellular and plasma DNA but in none of the ALL samples. Hemizygous/homozygous FLT3 ITD was detected in five (28%) of the FLT3 ITD-positive AML using plasma DNA, whereas only four of these cases showed hemizygous/homozygous FLT3 ITD using cellular DNA. The presence of FLT3 ITD was associated with significantly shorter survival (Pā€‰=ā€‰0.02) when only patients younger than 50 years of age (48 AML+MDS patients) were considered. This finding was independent of cytogenetics in this age group. However, patients with the FLT3 ITD hemizygous/homozygous phenotype had even shorter survival (Pā€‰=ā€‰<0.001). As expected, the presence of FLT3 ITD correlated with higher white blood cell (WBC) counts. These data demonstrate that plasma DNA is a reliable alternative resource for detecting FLT3ITD, especially the hemizygous/homozygous genotype. Furthermore, the data derived from this study support the notion that the presence of FLT3 ITD in conjunction with the absence of the wild-type FLT3 allele predicts an especially poor prognosis for patients with AML.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Mathews, W, Jordan, CT, Wiegand, GW, Pardoll, D & Lemischka, IR A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell, (1991). 65, 1143ā€“1152.

    ArticleĀ  Google ScholarĀ 

  2. Rosnet, O, Mattei, MG, Marchetto, S & Birnbaum, D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics, (1991). 9, 380ā€“385.

    ArticleĀ  CASĀ  Google ScholarĀ 

  3. Small, D, Levenstein, M & Kim, E STK-1, the human homolog of FLK-2/FLT3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor stem cells. Proc Natl Acad Sci USA, (1993). 91, 459ā€“463.

    ArticleĀ  Google ScholarĀ 

  4. Lyman, SD, Marmes, L, Zappone, J, Sleath, PR, Beckman, MP & Bird, T Characterization of the protein encoded by the FLT3 (flk2) receptor-like tyrosine kinase gene. Oncogene, (1993). 8, 815ā€“822.

    CASĀ  Google ScholarĀ 

  5. Rosnet, O, Schiff, C, Pubusque, MJ, Marchetto, S, Tonnelle, C, Toiran, Y, Birg, F & Birnbaum, D Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood, (1993). 82, 1110ā€“1119.

    CASĀ  PubMedĀ  Google ScholarĀ 

  6. McKenna, HJ, Smith, FO, Brasel, K, Hirshstein, D, Bernstein, ID, Williams, DE & Lyman, SD Effects of FLT3 ligand on acute myeloid and lymphocytic leukemic blasts from children. Exp Hematol, (1996). 24, 378ā€“385.

    CASĀ  PubMedĀ  Google ScholarĀ 

  7. Lisovskey, M, Estrov, Z, Shang, X, Consoli, U, Sanchez-Williams, G, Snell, V, Munker, R, Goodacre, A, Savchenko, V & Andreef, M FLT 3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood, (1996). 88, 3987ā€“3997.

    Google ScholarĀ 

  8. Stacchini, A, Fubini, L, Severino, A, Sanavio, F, Aglietta, M & Piacibello, W Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. Leukemia, (1996). 10, 1584ā€“1591.

    CASĀ  Google ScholarĀ 

  9. Dresler, HG Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia, (1996). 10, 588ā€“599.

    Google ScholarĀ 

  10. Dehmel, U, Zaborski, M, Meierhoff, G, Rosnet, O, Birnbaum, D, Ludwig, WD, Quentmeier, H & Drexler, HG Effects of FLT3 ligand on human leukemia cells. Leukemia, (1996). 10, 261ā€“270.

    CASĀ  PubMedĀ  Google ScholarĀ 

  11. Kiyoi, H, Kanano, Y, Yokota, S, Minami, S, Miyawaki, S, Asou, N, Kuriyama, K, Jinnai, I, Shimazaki, C, Akiyama, H, Saito, K, Oh, H, Motoji, T, Omoto, E, Saito, H, Ohno, R & Ueda, R Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood, (1999). 93, 3074ā€“3080.

    CASĀ  Google ScholarĀ 

  12. Brasel, K, Escobar, S, Anderberg, R, de Vries, P, Gurss, HJ & Lyman, SD Expression of the FLT3 receptor and its ligand on hematopoietic cells. Leukemia, (1996). 9, 1212ā€“1218.

    Google ScholarĀ 

  13. Jamal, R, Taketani, T, Taki, T, Bessho, F, Hongo, T, Hamaguchi, H, Horiike, S, Taniwaki, M, Hanada, R, Nakamura, H & Hayashi, Y Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia. Genes Chromosomes Cancer, (2001). 2, 187ā€“190.

    ArticleĀ  Google ScholarĀ 

  14. Rosnet, O, Mattei, MG, Marchetto, S & Birnbaum, D Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics, (1991). 9, 380ā€“385.

    ArticleĀ  CASĀ  Google ScholarĀ 

  15. Stirewalt, DL, Kopecky, KJ, Meshinchi, S, Appelbaum, FR, Slovak, ML, Willman, CL & Radich, JP FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood, (2001). 97, 3589ā€“3595.

    ArticleĀ  CASĀ  Google ScholarĀ 

  16. Kioyi, H, Towatari, M, Yokota, S, Hamaguchi, M, Ohno, R, Saito, H & Naoe, T Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia, (1998). 12, 1333ā€“1337.

    ArticleĀ  Google ScholarĀ 

  17. Fenski, R, Flesch, K, Serve, S, Mizuki, M, Oelmann, E, Kratz-Albers, K, Kienast, J, Leo, R, Schwartz, S, Berdel, WE & Serve, H Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells. Br J Haematol, (2000). 108, 322ā€“330.

    ArticleĀ  CASĀ  Google ScholarĀ 

  18. Tse, KF, Mukherjee, G & Small, D Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia, (2000). 14, 1766ā€“1776.

    ArticleĀ  CASĀ  Google ScholarĀ 

  19. Hayakawa, F, Kiyoi, H, Tanimoto, M, Kitamura, T, Saito, H & Naoe, T Tandem-duplicated FLT3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene, (2000). 19, 624ā€“631.

    ArticleĀ  CASĀ  Google ScholarĀ 

  20. Nakao, M, Yokota, S, Iwai, T, Kaneko, H, Horiike, S, Kashima, K, Sonoda, Y, Fujimoto, T & Misawa, S Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia, (1996). 10, 1911ā€“1918.

    CASĀ  Google ScholarĀ 

  21. Rombouts, W, Blokland, I, Lowenberg, B & Plemacher, R Biological characteristic and prognosis of adult acute myeloid leukemia with internal tandem duplications in the FLT3 gene. Leukemia, (2000). 14, 675ā€“683.

    ArticleĀ  CASĀ  Google ScholarĀ 

  22. Kottaridis, P, Gale, R & Frew, M The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the MRC AML 10 and 12 trials. Blood, (2000). 96, 825a

    Google ScholarĀ 

  23. Meshinchi, S, Woods, W, Stirewalt, D, Sweetser, DA, Buckley, JD, Tjoa, TK, Bernstein, ID & Radich, JP Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia. Blood, (2001). 97, 89ā€“94.

    ArticleĀ  CASĀ  Google ScholarĀ 

  24. Rombouts, WJC, Broyl, A, Martens, ACM, Slater, R & Ploemacher, RE Human acute myeloid leukemia cells with internal tandem duplications in the FLT3 gene show reduced proliferative ability in stroma supported long-term cultures. Leukemia, (1999). 13, 1071ā€“1078.

    ArticleĀ  CASĀ  Google ScholarĀ 

  25. Whitman, SP, Archer, KJ, Feng, L, Baldus, C, Becknell, B, Carlson, BD, Carroll, AJ, Mrozek, K, Vardiman, JW, George, SL, Kolitz, JE, Larson, RA, Bloomfield, CD & Caligiuri, MA Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res, (2001). 61, 7233ā€“7239.

    CASĀ  PubMedĀ  Google ScholarĀ 

  26. Mauritzson, N, Johansson, B, Rylander, L, Albin, M, Stromberg, U, Billstrom, R, Ahlgren, T, Mikoczy, Z, Mitelman, F, Hagmar, L & Nilsson, PG The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex. Br J Haematol, (2001). 113, 347ā€“356.

    ArticleĀ  CASĀ  Google ScholarĀ 

  27. Chen, X, Bonnefoi, H, Diebold-Berger, S, Lyautey, J, Lederrey, C, Faltin-Traub, E, Stroun, M & Anker, P Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res, (1999). 5, 2297ā€“2303.

    CASĀ  Google ScholarĀ 

  28. Nakayama, T, Taback, B, Nguyen, DH, Chi, DD, Morton, DL, Fujiwara, Y & Hoon, DS Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients. Ann N Y Acad Sci, (2000). 906, 87ā€“98.

    ArticleĀ  CASĀ  Google ScholarĀ 

  29. Starosktik, P, Manshouri, T, O'Brien, S, Freireich, E, Kantarjian, H, Haidar, M, Lerner, S, Keating, M & Albitar, M Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res, (1998). 58, 4552ā€“4557.

    Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jilani, I., Estey, E., Manshuri, T. et al. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia 17, 114ā€“119 (2003). https://doi.org/10.1038/sj.leu.2402743

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402743

Keywords

This article is cited by

Search

Quick links